As our results showed that the improved efficacy of CurDCs to control the established tumour is dependent on IL-9, we believe that even if CurDC improved the T-cell activation, proliferation or survival or DC survival, Th9 induction by CurDCs played the most important role for the observed antitumour responses. The gene discussed is IL9; the disease is neoplasm.